Literature DB >> 22661050

Uveitis with occult choroiditis due to Mycobacterium kansasii: limitations of interferon-gamma release assay (IGRA) tests (case report and mini-review on ocular non-tuberculous mycobacteria and IGRA cross-reactivity).

Tatiana I Kuznetcova1, Alain Sauty, Carl P Herbort.   

Abstract

Ocular tuberculosis is difficult to diagnose but should be suspected when uveitis fails to respond to inflammation suppressive therapy. Interferon-gamma release assays (IGRAs) represent a substantial help to diagnose suspected ocular tuberculosis especially in non-endemic areas. Indocyanine green angiography (ICGA) is able to detect clinically silent choroiditis that, when associated with a positive IGRA test, should lead the clinician to suspect ocular tuberculosis, warranting specific therapy. The fact that IGRA tests can also react with some atypical strains of mycobacteria is not always known. We report here a case with resistant post-operative inflammation that presented with occult ICGA-detected choroiditis and a positive IGRA test that was most probably due to the non-tuberculous mycobacterium (NTM) Mycobacterium kansasii. A 66 year-old man presented with a resistant cystoid macular oedema (CMO) in his left eye after combined cataract and epiretinal membrane surgery. At entry, his best-corrected visual acuity (BCVA) was 0.5 for far and near OS. Intraocular inflammation measured by laser flare photometry was elevated in the left eye (54.4 ph/ms) and also in the right eye (50.9 ph/ms). Four subTenon's injections of 40 mg of triamcinolone did not produce any substantial improvement. Therefore a complete uveitis work-up was performed. Fluorescein angiography showed CMO OS and ICGA showed numerous hypofluorescent dots and fuzziness of choroidal vessels in both eyes. Among performed laboratory tests, the QuantiFERON®-TB Gold test was positive. After a pulmonological examination disclosing a right upper lobe infiltrate, the patient was started on a triple anti-tuberculous therapy. Bronchial aspirate, obtained during bronchoscopy, was Ziehl-positive and culture grew M. kansasii. Nine months later, BCVA OS increased to 1.0 and flare decreased to 40.2 ph/ms. The CMO OS resolved angiographically and did not recur with a macula still slightly thickened on OCT. Suspected ocular tuberculosis based on clinical findings and a positive IGRA test can, in rare instances, be due to atypical mycobacteria that also produce positive IGRA tests such as M. kansasii, M. szulgai, M. gordonae, M. flavescens and M. marinum. In our case failure to isolate the atypical mycobacterium would not have had negative therapeutic consequences, as M. kansasii is sensitive to the standard anti-tuberculous treatments, which is not the case with other NTMs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22661050     DOI: 10.1007/s10792-012-9588-3

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  44 in total

1.  Mycobacterium szulgai keratitis.

Authors:  B E Frueh; O Dubuis; P Imesch; M Böhnke; T Bodmer
Journal:  Arch Ophthalmol       Date:  2000-08

2.  Bilateral Mycobacterium abscessus keratitis after laser in situ keratomileusis.

Authors:  JoAnn Giaconi; Randal Pham; Christopher N Ta
Journal:  J Cataract Refract Surg       Date:  2002-05       Impact factor: 3.351

3.  Assessment of cross-reactivity between Mycobacterium bovis and M. kansasii ESAT-6 and CFP-10 at the T-cell epitope level.

Authors:  H Martin Vordermeier; Jemma Brown; Paul J Cockle; Willeke P J Franken; Jan Wouter Drijfhout; Sandra M Arend; Tom H M Ottenhoff; Keith Jahans; R Glyn Hewinson
Journal:  Clin Vaccine Immunol       Date:  2007-08-01

4.  Chronic endophthalmitis after extracapsular cataract extraction caused by Mycobacterium chelonae subspecies abscessus.

Authors:  A M El-Asrar; K F Tabbara
Journal:  Eye (Lond)       Date:  1995       Impact factor: 3.775

5.  Ocular infections caused by non-tuberculous mycobacteria: update on epidemiology and management.

Authors:  Dalia O Girgis; Carol L Karp; Darlene Miller
Journal:  Clin Exp Ophthalmol       Date:  2011-11-04       Impact factor: 4.207

6.  Disseminated Mycobacterium kansasii infection with hepatic abscesses in a renal transplant recipient.

Authors:  P Kaur; J A Fishman; J Misdraji; M C Varma; C N Kotton
Journal:  Transpl Infect Dis       Date:  2011-04-05       Impact factor: 2.228

Review 7.  Infections due to non-tuberculous mycobacteria (NTM).

Authors:  V M Katoch
Journal:  Indian J Med Res       Date:  2004-10       Impact factor: 2.375

8.  [Detection of mycobacterial DNA with polymerase chain reaction in eye discharge and gastric juices in a case of scleritis].

Authors:  K Tanemoto; H Ishikawa; K Kigasawa; H Obazawa; H Fusegawa; H Miyachi; Y Ando
Journal:  Nippon Ganka Gakkai Zasshi       Date:  1997-01

9.  Mycobacterium avium-intracellulare corneal ulcer.

Authors:  A Knapp; G A Stern; C I Hood
Journal:  Cornea       Date:  1987       Impact factor: 2.651

Review 10.  Diagnosing tuberculosis infection in the 21st century: new tools to tackle an old enemy.

Authors:  Ajit Lalvani
Journal:  Chest       Date:  2007-06       Impact factor: 9.410

View more
  14 in total

Review 1.  Management of nontuberculous mycobacterial infection in the elderly.

Authors:  Mehdi Mirsaeidi; Maham Farshidpour; Golnaz Ebrahimi; Stefano Aliberti; Joseph O Falkinham
Journal:  Eur J Intern Med       Date:  2014-03-29       Impact factor: 4.487

2.  Mycobacterial skin and soft tissue infection.

Authors:  Shu-Hua Wang; Preeti Pancholi
Journal:  Curr Infect Dis Rep       Date:  2014-11       Impact factor: 3.725

3.  Caveats about QuantiFERON-TB gold in-tube testing for uveitis.

Authors:  Kathryn L Pepple; Russell Van Gelder; Farzin Forooghian
Journal:  Am J Ophthalmol       Date:  2014-04       Impact factor: 5.258

4.  Evaluating latent tuberculosis infection diagnostics using latent class analysis.

Authors:  Jason E Stout; Yanjue Wu; Christine S Ho; April C Pettit; Pei-Jean Feng; Dolly J Katz; Smita Ghosh; Thara Venkatappa; Ruiyan Luo
Journal:  Thorax       Date:  2018-07-07       Impact factor: 9.139

5.  Infectious Uveitis.

Authors:  Phoebe Lin
Journal:  Curr Ophthalmol Rep       Date:  2015-06-13

6.  The spectrum of presumed tubercular uveitis in Tunisia, North Africa.

Authors:  Sana Khochtali; Salma Gargouri; Nesrine Abroug; Imen Ksiaa; Sonia Attia; Dorra Sellami; Jamel Feki; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2014-09-06       Impact factor: 2.031

Review 7.  Nontuberculous Mycobacterial Ocular Infections: A Systematic Review of the Literature.

Authors:  Wajiha J Kheir; Huda Sheheitli; Maamoun Abdul Fattah; Rola N Hamam
Journal:  Biomed Res Int       Date:  2015-05-27       Impact factor: 3.411

8.  The performance of interferon-gamma release assay in nontuberculous mycobacterial diseases: a retrospective study in China.

Authors:  Mao-Shui Wang; Jun-Li Wang; Xin-Feng Wang
Journal:  BMC Pulm Med       Date:  2016-11-25       Impact factor: 3.317

9.  Perspectives of Quantiferon TB Gold test among Indian practitioners: a survey.

Authors:  Kalpana Babu; Mariamma Philips; Doddaballapur Krishnaswamy Subbakrishna
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-01-11

10.  Non-tuberculous mycobacteria and the performance of interferon gamma release assays in Denmark.

Authors:  Thomas Stig Hermansen; Vibeke Østergaard Thomsen; Troels Lillebaek; Pernille Ravn
Journal:  PLoS One       Date:  2014-04-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.